A special fatty acid from a healthy diet may help heal nerves damaged by MS.
Researchers discovered that propionic acid, a fatty acid from high-fiber foods, can help repair damaged nerve connections in MS patients. They tested this by looking at nerve cells made from MS patients and found that these cells recovered better when treated with propionic acid. Additionally, another fatty acid called butyric acid also helped improve nerve recovery when used alongside propionic acid. The study showed that these fatty acids change how certain proteins work in the cells, which is important for healing. This is like how a good fertilizer helps plants grow stronger and recover from damage.
MS patients should pay attention because these findings suggest that adding more fiber to their diet might support nerve healing. Caregivers can use this information to encourage healthy eating habits that may improve their loved ones' symptoms. Healthcare providers can consider diet as an important part of MS treatment, just like they would with medications. This can lead to more comprehensive care that addresses both diet and medication. Just like watering a plant helps it flourish, a good diet might help MS patients feel better and recover more effectively.
The study mainly focused on lab-grown nerve cells, so we don't yet know if these results will be the same in real-life situations for MS patients. Not all MS patients may respond the same way to dietary changes, as everyone's body is different. It's important for MS patients to talk to their doctor before making any big changes to their diet.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain communications often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.